LEPTOMENINGEAL CARCINOMATOSIS

Clinical trials for LEPTOMENINGEAL CARCINOMATOSIS explained in plain language.

Never miss a new study

Get alerted when new LEPTOMENINGEAL CARCINOMATOSIS trials appear

Sign up with your email to follow new studies for LEPTOMENINGEAL CARCINOMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Immune-Boosting drugs tested against devastating brain fluid cancer

Disease control Completed

This study tested a combination of two immunotherapy drugs, ipilimumab and nivolumab, for a serious condition where cancer spreads to the fluid surrounding the brain and spinal cord. It involved 18 adults with this advanced complication from various solid tumors. The goal was to …

Matched conditions: LEPTOMENINGEAL CARCINOMATOSIS

Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

LEPTOMENINGEAL CARCINOMATOSIS

Get alerted when new LEPTOMENINGEAL CARCINOMATOSIS trials appear

Immune-Boosting drugs tested against devastating brain fluid cancer